Pharmaceutical

Opinion: I learned the hard way that U.S. airlines are not currently required to have EpiPens

Opinion: I learned the hard way that U.S. airlines are ...

Aug 1, 2023

Since 2016, airlines have been able to apply for “emergency” exemptions to the r...

Opinion: The airline industry needs some disaster management lessons. Health care can help

Opinion: The airline industry needs some disaster manag...

Aug 1, 2023

People like to say health care should be more like the airline industry. This su...

Primary care physicians are learning how to fill the gaps in gender-affirming medicine

Primary care physicians are learning how to fill the ga...

Aug 1, 2023

"We make gender-affirming care specialty care, and that automatically creates ba...

STAT+: Flow Neuroscience shows promising results in trial of brain-stimulation headset for depression

STAT+: Flow Neuroscience shows promising results in tri...

Aug 1, 2023

Flow is seeking FDA approval of its headset device, which uses transcranial dire...

STAT+: Medicare wants to improve Alzheimer’s care, but sidesteps drug prices

STAT+: Medicare wants to improve Alzheimer’s care, but ...

Aug 1, 2023

Medicare wants to improve dementia care and reduce the strain on unpaid caregive...

Vivek Ramaswamy wants to ‘gut’ the FDA. His claims don’t hold up to scrutiny

Vivek Ramaswamy wants to ‘gut’ the FDA. His claims don’...

Aug 1, 2023

Presidential candidate Vivek Ramaswamy recently posted a video trading on his bi...

NIH begins long-delayed clinical trials for long Covid, announces new research office

NIH begins long-delayed clinical trials for long Covid,...

Aug 1, 2023

One trial involving Paxlovid is already underway.

STAT+: Pharmalittle: House Republicans and Democrats duel over drug shortages; FDA approves second over-the-counter naloxone

STAT+: Pharmalittle: House Republicans and Democrats du...

Aug 1, 2023

House Republicans have drafted drug-shortage legislation that differs significan...

Non-profit receives FDA approval to supply cheaper OTC naloxone

Non-profit receives FDA approval to supply cheaper OTC ...

Jul 31, 2023

Harm Reduction Therapeutics won FDA approval for the second OTC naloxone nasal s...

Searchlight licenses Mithra’s menopause drug Donesta for Canadian market

Searchlight licenses Mithra’s menopause drug Donesta fo...

Jul 31, 2023

Mithra Pharmaceuticals is in line to receive €17.05m ($18.8m) in licencing fees,...

Santhera fully divests rare eye disease drug Raxone to Chiesi

Santhera fully divests rare eye disease drug Raxone to ...

Jul 31, 2023

Santhera Pharmaceuticals announced the complete worldwide divestment of Raxone (...

How big data M&A performed in the pharmaceutical indust...

Jul 31, 2023

In the global pharmaceutical industry, there were 3 M&A deals announced in Q2 20...

How immuno-oncology private equity performed in the pha...

Jul 31, 2023

In the global pharmaceutical industry, there were 6 private equity deals announc...

How regenerative medicine M&A performed in the pharmace...

Jul 31, 2023

In the global pharmaceutical industry, there were 4 M&A deals announced in Q2 20...

M&A in pharmaceutical in Italy increased in Q2 2023

Jul 31, 2023

In Italy pharmaceutical industry, there were 7 M&A deals announced in Q2 2023, w...

M&A in pharmaceutical in Germany increased in Q2 2023

Jul 31, 2023

In Germany pharmaceutical industry, there were 12 M&A deals announced in Q2 2023...